Luc Buee PhD, MSc

Luc Buee is a French scientist (CNRS Research Director), Director of the Jean-Pierre Aubert Research Centre and Head of the Inserm laboratory « Alzheimer & Tauopathies at the University of Lille, France. His group is also part of the laboratory of Excellence (LabEx) DISTALZ and the Centre of Excellence in Neurodegenerative disorders (LiCEND).

He has worked on Alzheimer disease and related disorders for more than twenty five years. He started his work on the role of proteoglycans in Alzheimer disease with a PhD training at Mount Sinai Medical Center, NYC. He was then involved in the initial characterization of tau aggregates among neurodegenerative disorders. He has then developed experimental models to better understand the role of post-translational modifications in tau aggregation and tau secretion. His group is currently working on the pathophysiological consequences of neurofibrillary degeneration and their links to the amyloid pathology in Alzheimer disease. His group was/is also involved in different international consortia. Luc Buee was also a delegate at the Inserm Board for scientific evaluations in Neurosciences (CSS 6, 2012-2016).

Luc Buée is also involved in different scientific advisory boards and operating committees in the field of AD. He is also the representative researcher elected by academics at the French Foundation Plan Alzheimer. Since October 2017, he is the vice-president of the French Society for Neuroscience.